Alkermes plc News
Glaxo Rises as Elliott Takes Hefty Stake in Drugmaker
The size of Elliott's stake in Glaxo wasn't disclosed. Elliott is headed by iconic investor Paul Singer. Glaxo's shares rose.
Alkermes Climbs as FDA Accepts New Drug Application Resubmission
Alkermes' schizophrenia and bipolar disorder treatment candidate is once again being reviewed by the FDA.
Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round
Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.
Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap
Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.
Alkermes wins quick reversal from FDA on antidepressant drug
Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.
American Medical Association Rejects Idea of Time Limits On Opioid Scripts
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
Dow Comes Off Session Lows, Finishes Day Down More Than 400 Points
Stocks finish down sharply on Monday, the first trading day of the second quarter, after China's Ministry of Finance announces new tariffs of up to 25% on certain U.S. products.
Alkermes surprised, angered by FDA rejection of antidepressant
Alkermes says the rejection of antidepressant drug ALKS 5461 is a head-scratcher, and it's calling for a prompt meeting with the regulator to get to the bottom of the decision.
Trump's Opioid Plan Gives Alkerme's Vivitrol Drug a Sales Boost
Alkermes has spent money lobbying and donating to elected officials, and in the White House opioid plan, it seems to have paid off, as opioid blocker Vivitrol becomes part of prison protocol.
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Apple Preparing For iPhone 14 Launch On September 7 - Report
Bloomberg reported late Wednesday that Apple is eyeing a September 7 launch date for its new iPhone 14 series.
Bed, Bath & Beyond Stock Dives As Ryan Cohen Moves to Sell Entire Stake
Ryan Cohen, who pushed for changes at Bed, Bath & Beyond including the ouster of CEO Mark Tritton, is looking to dump his entire 11.8% stake in the struggling home retailer.